|
| 武汉地区2000～2002年降脂药用药情况分析 |
| A Study of the Medication of Antihyperlipidemic Drugs in Wuhan During 2000～2002 |
| 投稿时间：2004-03-30 修订日期：2004-06-28 |
| DOI： |
| 中文关键词: 武汉 降脂药 他汀类降脂药 药物利用 |
| 英文关键词:Antihyperlipidemic drugs Statins Drug utilization |
| 基金项目: |
| 王奕 毛德莉 |
| 武汉市中心医院,武汉430014 |
| 摘要点击次数: 2539 |
| 全文下载次数: 109 |
| 中文摘要: |
| 目的：探讨武汉地区降脂药的应用状况及市场趋势。方法：分类统计武汉地区2000～2002年降脂药数据资料。结果：他汀类作为降脂药中的一线药物，占有58．22％的份额，具有很大优势。结论：合理选择疗效确切的降脂药意义重大。 |
| 英文摘要: |
| Objective: To investigate the administration and market trend of antihyperlipidemic drugs in Wuhan. Method: The sum and proportion of five kinds of antihyperlipidemic drugs used in twenty-three hospitals in Wuhan from 2000 to 2002 were studied. Result:The statins of antihyperlipidemic drugs is the most important drug to treat hyperlipidemia and accounts for 58. 22% in the market of antihyperlipidemic drugs and has its great advantage. Conclusion:It is the most important to reasonably select antihyperlipidemic drugs of definite effectiveness. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
